Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Breast Neoplasms 52Carcinoma, Renal Cell 47Neoplasm Metastasis 24Neoplasms 18Kidney Neoplasms 18Neuroendocrine Tumors 17Carcinoma, Non-Small-Cell Lung 13Tuberous Sclerosis 12Stomach Neoplasms 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 11Recurrence 10Prostatic Neoplasms 10Lymphoma 10Hodgkin Disease 10Glioblastoma 10Colorectal Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Brain Neoplasms 9Lymphoma, Follicular 8Lung Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 8Carcinoma 8Waldenstrom Macroglobulinemia 7Triple Negative Breast Neoplasms 7Sarcoma 7Multiple Myeloma 7Lymphoma, B-Cell, Marginal Zone 7Glioma 7Central Nervous System Neoplasms 7

Interventions

Irinotecan 30Paclitaxel 24Gemcitabine 21Cisplatin 21Docetaxel 19Fluorouracil 15alvocidib 12Oxaliplatin 11Leucovorin 11Carboplatin 11Capecitabine 11Bortezomib 9Taxes 8Topotecan 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Vorinostat 6Immunohistochemistry 6tanespimycin 5Temozolomide 5Sorafenib 5Pemetrexed 5Early Intervention, Educational 5Chromatography, High Pressure Liquid 5Bevacizumab 57-hydroxystaurosporine 57-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine 5ixabepilone 4bryostatin 1 4Sirolimus 4Pharmacogenomic Testing 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Unspecified Adult Solid Tumor, Protocol Specific × Everolimus × Clear all
NCT01566279 2018-03-09

CPCT-03

UMC Utrecht

Phase NA Completed
73 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00610948 2017-05-04

Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
74 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00423865 2015-05-25

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
30 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00276575 2014-11-19

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

Duke University

Phase 1 Completed
65 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡